Dataset Information


ChIP-MS for GR in liver from wild type and E47 mutant mice

ABSTRACT: Glucocorticoids (GCs) are widely prescribed effective drugs, but their clinical use is compromised by severe side effects including hyperglycemia, hyperlipidemia and obesity. They bind to the Glucocorticoid Receptor (GR), which acts as a ligand-gated transcription factor. The transcriptional activation of metabolic genes by GR is thought to underlie these undesired adverse effects. Using mouse genetics, ChIP-Seq, RNA-Seq and ChIP-MS, we found that the bHLH transcription factor E47 is required for the regulation of hepatic glucose and lipid metabolism by GR in vivo, and that loss of E47 prevents the development of hyperglycemia and hepatic steatosis in response to GCs. Here we show that E47 and GR co-occupy metabolic promoters and enhancers. E47 is needed for the efficient binding of GR to chromatin and for the adequate recruitment of coregulators such as Mediator. Taken together, our results illustrate how GR and E47 regulate hepatic metabolism, and how inhibition of E47 might provide an entry point for novel GC therapies with reduced side effect profiles. These ChIP-MS data sets show IPs for GR in both wildtype and E47 mutant mouse livers treated with the synthetic glucocorticoid Dexamethasone.


ORGANISM(S): Mus musculus  

TISSUE(S): Liver

DISEASE(S): Not Available

SUBMITTER: Michael Wierer  

PROVIDER: PXD010157 | Pride | 2018-11-22


Similar Datasets

2016-08-25 | E-GEOD-79431 | ArrayExpress
2019-02-15 | PXD012406 | Pride
2016-08-25 | E-GEOD-79429 | ArrayExpress
2019-02-15 | PXD012555 | Pride
2015-09-18 | E-GEOD-56022 | ArrayExpress
| GSE71102 | GEO
| GSE71099 | GEO
| GSE85343 | GEO
2016-08-25 | E-GEOD-79426 | ArrayExpress
| GSE119713 | GEO